Teleflex Reports Study Results of ARROWg+ard® Technology Effectiveness in Reducing Catheter Infections and Costs in Low Risk Population

Go back to Teleflex Reports Study Results of ARROWg+ard® Technology Effectiveness in Reducing Catheter Infections and Costs in Low Risk Population
TELEFLEX INCORPORATED (NYSE: TFX) Delayed: 138.36 -1.6 (1.14%)
Previous Close $139.96    52 Week High $188.79 
Open $138.70    52 Week Low $125.28 
Day High $140.59    P/E 39.99 
Day Low $137.35    EPS $3.46 
Volume 464,473